e 64 has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cunha, RLOR; Juliano, L; Machado-Santelli, GM; Martens, AA; Omori, ÁT; Paschoalin, T; Pereira, FV; Travassos, LR | 1 |
| Kurita, Y; Nakao, H; Ogawa, H; Takamori, K; Tsuboi, R | 1 |
2 other study(ies) available for e 64 and B16 Melanoma
| Article | Year |
|---|---|
Antitumor effect of chiral organotelluranes elicited in a murine melanoma model.
Topics: Actin Cytoskeleton; Animals; Antineoplastic Agents; Cathepsin B; Cathepsin L; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Human Umbilical Vein Endothelial Cells; Humans; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Organometallic Compounds; Stereoisomerism; Tellurium | 2019 |
Differences in induction of lysosomal protease activity by protease inhibitors in B16 melanoma cell lines.
Topics: Acid Phosphatase; Animals; Cathepsin B; Enzyme Induction; Leucine; Leupeptins; Melanoma, Experimental; Mice; Oligopeptides; Pepstatins; Peptide Hydrolases; Protease Inhibitors; Subcellular Fractions; Tumor Cells, Cultured | 1989 |